EP Patent

EP1055665A1 — 3-(3-Hydroxyphenyl)-3-amino-propionamide derivatives

Assigned to Pfizer Products Inc · Expires 2000-11-29 · 25y expired

What this patent protects

The present invention relates to compounds of the formula I, wherein X, Y, R 1 , R 2 and R 3 are defined as in the specification, pharmaceutical compositions containing such compounds the use of such compounds to treat neurological and gastrointestinal disorders.

USPTO Abstract

The present invention relates to compounds of the formula I, wherein X, Y, R 1 , R 2 and R 3 are defined as in the specification, pharmaceutical compositions containing such compounds the use of such compounds to treat neurological and gastrointestinal disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP1055665A1
Jurisdiction
EP
Classification
—
Expires
2000-11-29
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Products Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.